Market Overview

TriplePoint Venture Growth Q4 Earnings Preview


On Monday, TriplePoint Venture Growth (NYSE: TPVG) will release its latest earnings report. Benzinga's report can help you figure out the ins and outs of the earnings release.

Earnings and Revenue

Wall Street analysts see TriplePoint Venture Gwth reporting earnings of 32 cents per share on revenue of $11.69 million.

The analyst consensus estimate would represent a 6.67 percent increase in the company's EPS figure. Sales would be up 9.78 percent on a year-over-year basis. Here's how the company's reported EPS has stacked up against analyst estimates in the past:


Quarter Q3 2017 Q2 2017 Q1 2017 Q4 2016
EPS Estimate 0.24 0.32 0.47 0.35
EPS Actual 0.27 0.55 0.5 0.3


Stock Performance

Over the last 52-week period, shares are down 11.27 percent. Given that these returns are generally negative, long-term shareholders are probably upset going into this earnings release. Over the past 90 days, analysts have generally adjusted their estimates higher for EPS and revenues. The most common rating by analysts on TriplePoint Venture Gwth stock is a Neutral. The strength of this rating has maintained conviction over the past three months.

Conference Call

TriplePoint Venture Gwth's Q4 is scheduled to hold a conference call at 4:00 p.m. ET and it can be accessed here.

Posted-In: Earnings News Previews Trading Ideas


Related Articles (TPVG)

View Comments and Join the Discussion!
Fastest Market News Application
You'll Hear It First On Pro
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at

5 Biggest Price Target Changes For Monday

Earnings Outlook For Tabula Rasa HealthCare